• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Global Tissue and Organ Transplantation Market to Surpass $25.6 Billion by 2027

    Owlstone Medical Introduces Breath Biopsy Panel for Respiratory Diseases

    Cognoptix Forms a New Board of Directors

    Occlutech's Atrial Flow Regulator Earns Breakthrough Status for HF

    FDA OKs MRI for Impulse Dynamics' Optimizer CCM Delivery Systems
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Fixing Face Mask Form and Function

    The Heart of the Matter: Trends in Cardiology

    Virtually the Same? The Challenges of Online Conferences

    Digital Health Delivers During a Year for the Ages

    Advanced Technology for Staking and Swaging Medical Plastics
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Spectrum Plastics Group

    Creganna Medical, part of TE Connectivity

    Unicep

    Element

    Medicoil
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Meeting Critical Ventilator Product Requirements Amid Pandemic

    Impact of COVID-19 on the Medtech Supply Chain

    Finding the Upside to a Challenging Year

    Preparing Your Design Controls for FDA Approval

    A 'Trial and Error' Approach to Micromolded Parts
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    FUTEK Advanced Sensor Technology Inc.

    Creganna Medical, part of TE Connectivity

    PTI Engineered Plastics Inc.

    K-Tube Technologies

    Spectrum Plastics Group
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Features

    Research, Develop, Produce, Repeat

    Medical device research and development strategy urges moderation and market analysis.

    Research, Develop, Produce, Repeat
    Strong clinical and medical aptitude is key for translating customer needs into a successful development program. Image courtesy of Freudenberg Medical.
    Research, Develop, Produce, Repeat
    Successful companies use ideation sessions to nurture the creativity that leads to innovative solutions. Image courtesy of Farm.
    Related CONTENT
    • Medtech Matters: Surgeons Scrubbing In Virtually
    • FineHeart Successfully Tests Wireless TET System
    • Moon Surgical Expands Leadership Team
    • CMS Expedites Breakthrough Device Access; Industry Applauds
    • Medtech Matters: Talking Robotic Surgery with Zimmer Biomet
    Sam Brusco, Associate Editor01.30.17
    Some called it  “the crunch enjoyed around the world.”

    In order to more adequately grasp consumer preferences, back in 2011 PepsiCo, owner of the Frito-Lay potato chip brand, conducted market research on what core customers—in this case, young men—wanted from their potato chips. Not surprisingly, the researchers discovered taste wasn’t the only important attribute; texture, aroma, and convenience also factored into the enjoyment of the snack. After a number of consumer surveys and undoubtedly delicious research with focus groups, it became clear that snackers desired a heartier chip. Believe it or not, that simple request turned out to be quite the engineering challenge. How could a hearty chip be designed while still retaining a thin composition?

    Frito-Lay’s answer: give snackers a more “three-dimensional” eating experience by manufacturing chips with a more pronounced corrugated pattern—potentially, with ridges twice as deep as then-typical Ruffles chips. It made perfect sense; deeper ridges would surely produce a more resounding crunch and double each chip’s dip capacity. Snackers everywhere would rejoice in crunchy delight! Unfortunately, that structural change was easier said than done. PepsiCo did not have the equipment to manufacture chips with deeper ridges and varying angles.

    After sweeping crumbs off the market research room floor, PepsiCo’s research and development team went to work on designing both cutting blades that could slice chips evenly without cracking them and the mechanism feeding them in correct alignment with the blade. In the process, concepts like “bending stress” and “blade tip geometry” were thrown around. (Keep in mind, this is the effort that goes into a seemingly innocuous snack.)

    “They approached the problem differently and drove deep fundamental understanding of the mechanical dynamics of potato slicing,” explained Kevin O’Sullivan, vice president of PepsiCo Advanced Research, in an “Innovation Story” on the firm’s website.

    The first “concept chips” were made with a slicer intended for French fries, but unfortunately cracked, compressed, and didn’t hold up when cooked. “They were irregular, had sharp peaks, and could not be used for consumer testing,” said Keith Barber, director at PepsiCo’s Frito-Lay North America Research and Development, in the same story.

    Rather than using the slicer for consumer design testing, the team computer modeled the chip and 3D printed over two-dozen potato chip prototypes, which varied in waviness and thickness. After narrowing this down to nine prototypes using a specially designed vegetable slicer, the chips were consumer tested and resulted in some of the highest consumer response scores the company had seen in decades. Using the vegetable slicer as a reference model, the R&D engineers designed a blade to fit Frito-Lay’s existing manufacturing equipment, testing and tweaking it along the way alongside optimal chip designs. The team took the newly designed blade to Frito-Lay’s manufacturing facility for full-scale testing and to hammer out any remaining technical challenges. The Ruffles Ultimate chips were finally rolled out in 2012 (and were incredibly well-received), revolutionizing potato chip design forever.

    The lesson to be learned here? An effective research and development strategy really is all that and a bag of chips.

    The Current State of Medical Device R&D
    The same ideas hold true for medical product development, but with an entirely different type of crunch. Because R&D activities don’t offer an immediate return on investment, there can often be a money crunch—that is, the uncertainty about how much funding to pour into R&D, and where precisely to pour it. Many stress the importance of the earliest design stages, so should more funding be allocated there? But a product can’t hit the market without validation and testing, so should those phases receive more funding?

    What’s more, thanks to the consumer demand for quicker turnaround on new devices, there is a time crunch for R&D activities as well. Move too slowly, and the product risks obsolescence. Move too quickly, and the product may not garner U.S. Food and Drug Administration approval—or worse, contain a design flaw that risks a recall or endangers patients.

    For that reason, OEMs turn to firms that provide R&D services when time or money spent on developing a product becomes an issue internally. These companies provide the expertise necessary when bandwidth or monetary resources don’t exist for the OEM, and can be quite valuable due to their specialized knowledge and dedicated teams.

    Further, according to recent Advanced Medical Technology Association and Medical Device Manufacturers Association surveys, R&D investments are at a high point, due in a large part to the suspension of the medical device tax. So far, it seems funds not lost on the tax are being allocated where they should: to innovation. The surveys found:
    • 83 percent of the respondents reported increased R&D funding, or avoided reducing R&D funding.
    • 33 percent invested in a new research facility, lab, or research infrastructure.
    • When asked how much they had increased their R&D budget, the average increase was 19 percent.
    Perhaps most notably, approximately 75 percent of the respondents said they would make additional investments in both job creation (dedicated research and development teams, perhaps?) and R&D activities if the device tax were permanently repealed, rather than temporarily suspended. In short, the extra funding resulting from the tax suspension is beginning to broaden the capabilities of firms to use R&D time and money effectively. Though at the moment it’s a temporary reprieve for device manufacturers, many are already noticing the effects—beyond simply the survey results.

    “Medical device R&D is growing faster than ever,” noted Jared Pack, a product development engineer for Morrisville, N.C.-based contract design and manufacturing firm EG-GILERO.

    The increased emphasis on the early-stage processes is having a favorable impact on patient outcomes and cost of treatment as well.

    “There is an ever-growing demand for higher quality and more cost-effective devices, and being able to provide these devices is a win-win for everyone involved,” Pack continued. “Better patient outcomes means lower malpractice risk, and that reduced cost can be carried through to the treatment cost for the patient.”

    “A significant source of R&D growth has been the result of mergers, acquisitions, and strategic partnerships,” illuminated José Wong, senior director of engineering and program management for Hollis, N.H.-based Farm, a full-service product development company. “Many companies see that organic growth or in-house efforts may be slower because of cost, company culture, and competing commitments. The model is moving increasingly toward acquiring or partnering with other specialized groups. Product development firms are in a great position to support organizations that need the creativity and expertise to innovate and grow. Collaboration also reduces risk, is cost-effective, and helps get the product to market more quickly.”

    “Despite being under significant pressure from the business environment (i.e., reduced levels of venture capital funding and a high degree of merger activity reducing the number of large OEMs), I am always impressed with the state of R&D in the medical device industry,” mused Kenneth Fine, president of Mansfield, Mass.-based full-service contract design and manufacturing firm Proven Process Medical Devices. “I enjoy learning of new devices and products that are treating conditions that were historically problematic. In the past, ‘me too’ devices that did not add significant value to healthcare were prevalent. The R&D efforts that I see today are directed towards products that add true value to patient care.”

    Though for the most part the state of R&D looks hopeful, the heavily regulated medical device industry puts unique pressures on firms specializing in these services. During development, devices are subject to certain validation requirements that only exist in the medical industry. Further, one phase of R&D consumes an immense amount of time and money, and exists nowhere but in the medical industry: clinical trials.

    “R&D is becoming more and more important, getting more complex, and the pressures on cost and time are tremendous,” said Lars Gerding, director of technology for Freudenberg Medical, a Carpinteria, Calif.-based full-service contract manufacturing firm. “Launching new products and getting ahead of the competition is extremely important for our customers. All the mergers within our industry greatly affect projects and R&D.”

    “R&D in the medical device industry continues to be challenged by increasing costs associated with the ever-changing and increased complexity of after tool build activities like validation requirements and clinical trials,” explained Benjamin Harp, chief operating officer of Orchard Park, N.Y.-based Polymer Conversions Inc., a full-service contract manufacturer specializing in thermoplastics. “Validation requirements continue to become more comprehensive as industry and the OEM try to control more and more of the production outputs. Controlling more dimensions requires more engineering touches, resulting in more dollars and time needed to properly validate the device. Clinical trials continue to get more regulated. Regulatory scrutiny results in R&D complexity, which increases costs and time needed to develop new technologies.”

    How OEMs Spend R&D Money
    Medical device OEMs today are under more pressure than ever to produce, and produce quickly. Another OEM with a comparable device and a speedier turnaround time for their product is just around the corner. But not every OEM can be a Medtronic or Boston Scientific with a team dedicated specifically to R&D, or millions of dollars to spend solely on development.

    It’s mainly due to this demand for faster and more efficient R&D (resulting in a speedier overall product development cycle) without the internal capabilities that firms providing these services are becoming so attractive. Rather than potentially wasting time and resources forging the necessary team and equipment to meet the demand, OEMs are noticing that their R&D money may be more aptly spent on a firm that is accustomed to a high-intensity R&D environment.

    “There are definitely cost pressures, but we still see a rise in medical device R&D spending,” commented Wong. “Companies realize that the competition is not standing still and it’s important to keep new products in the pipeline. That being said, budgets are tight, and valuable R&D teams are often redirected to support installed base engineering activities and/or are working on incremental product improvements or line-extensions. Because of this, we find that OEMs are outsourcing development activities to supplement their teams.”

    “We are always working on medical device technologies with our OEM clients,” Harp explained. But even those specializing in R&D services run into challenges along the way.

    “The costly challenges we see in R&D are when shortcuts are taken in development steps because of budget and time restraints,” he continued. “Sometimes, these shortcuts result in program delays and budget overruns. A common example we see is when prototypes are designed and built based on cost and time, sacrificing proper design for manufacturability and optimized device performance. This sometimes results in an extra round of design changes, prototype tooling, and trials, in support of the changes required. We encourage involvement of a manufacturing partner early on in R&D and product development activities to improve outputs.”

    “Research and development” is such a common phrase in any science—but for most, the definition stops there. There are in fact many, many different sections of R&D: design, testing, clinical trial, validation, quality assurance, and so on. Simply noting there is more medical device R&D spending overall is akin to saying the U.S. government is spending more on cancer research. That’s all well and good, but there are many different types of cancer and each of them requires different research tactics.

    Firms specializing in medical product research and development have the unique position of knowing exactly where OEMs spend most of their money during the process. They are also quicker to address areas they notice are underfunded.

    “I find that most of the R&D dollars are typically spent in verification and validation of the product, especially if human clinical studies are required to validate the device or if there was skimping in earlier parts of the R&D process,” illustrated Fine. “Unfortunately, I find design input activities are often the least funded part of the R&D process, even though this early phase establishes the basis and foundation for the device development.”

    Pack also agreed that OEMs should be paying more attention and dollars toward design activities, despite it being the earliest section of the development process. In fact, it’s because conceptual design is one of the initial steps in product development that it should be given more weight.

    “The most important part of the process is prior to any verifications or validations,” he asserted. “Ideally, before a project hits design freeze, the design should be so well understood that the engineers can predict the test outcomes with ease. This allows treatment of design verification/validation (DV) and process validation to be a ‘check box’ rather than a true test. If the early stages are underfunded, there is a risk of failing at DV, which causes time loss due to the quality processes that must occur at that time.”

    Interestingly enough, one challenge with R&D spending defies intuition. The device itself seems to be the focus of research and development funding, which seems like the obvious place to allocate resources. And why challenge that assumption? The device is the OEM’s end goal, and the return on all development resources expended. However, that appears to result in a dearth of funds in research and development resources that are equally as integral.

    “The most R&D money is spent on devices, not on improving production technologies or making products more affordable,” criticized Gerding. “These areas are underfunded. With a strong focus on new products and new devices, spending for components is more limited. We also see a lack of focus and spending on working with new materials—customers tend to want to use a particular material that they have worked with in the past.”

    A Balancing Act
    There doesn’t appear to be one answer to executing an effective medical device R&D strategy. Should more time be spent on design, or testing? How can money be allocated to production equipment when it’s already being spent on the product? One idea most firms providing these services can agree on is that research and development strategy requires a delicate balance between too much and too little, with regard to both time and money. As in many facets of life, moderation is key.

    “Spend too much time in R&D, and you run the risk of missing a market opportunity and being beat to the punch by a competitor,” advised Wong. “However, if you spend too little time, you risk running into product issues that may delay your launch, or deliver a less than optimal product with performance or quality issues. A company’s reputation is valuable, and risking a product launched with defects—even if they’re just minor annoyances—can be detrimental to a company’s brand and market position.”

    “The time needed to spend on any particular medical device R&D program should be a function of the product’s cost/benefit (which helps establish its profit margin along with the corresponding reimbursement), the opportunity window (before a competing technology obsoletes the device), its lifetime in the market, and its technological complexity,” explained Fine. “Spending too little time in R&D may yield a product that does not meet the needs of the stakeholders, has poor performance, is too costly to manufacture and service, or is unreliable. Spending too much time in R&D may cause the product to miss its window of market opportunity, have too short a market life to recoup sufficient costs, or become technologically obsolete too soon.”

    “If you spend too little time you get behind the competition; if you are not best in class, you are done,” warned Gerding. “Spending too much on R&D is not the issue; the issue is spending money on the wrong idea or the wrong device that doesn’t really take off. It’s essential to choose the right product, the right project. The challenge is how to access and evaluate all the ideas out there.”

    The advice is simple to understand, yet complicated to carry out: pay attention to the market and weigh the allocation of R&D resources against the device’s potential benefits—both financial and for patients.

    “Medical device R&D spending is a balancing act,” said Pack. “Spend too little, and the risks become creating a less effective and less reliable product. Most importantly, the risk of patient injury due to a design flaw increases if not enough time and money was spent to understand the device. Spending too little also risks not gaining regulatory approval for sale—especially with novel technology, which could invalidate the effort that was spent. However, spending too much could eliminate the return on the investment that was made, which isn’t good either. Making money is what allows further development and innovation.” 
    Related Searches
    • contract manufacturing
    • u.s. food and drug administration
    • assurance
    • first
    Related Knowledge Center
    • Contract Manufacturing
    • R&D & Design
    • Testing
    Suggested For You
    Perspectives on Post-Pandemic: Consider the IT Infrastructure Perspectives on Post-Pandemic: Consider the IT Infrastructure
    Perspectives on Post-Pandemic: Expect Supply Chain Security to Increase Perspectives on Post-Pandemic: Expect Supply Chain Security to Increase
    Medtech Matters: Medtronic Medtech Matters: Medtronic's Robotic Surgery Status
    Medtech Matters: Surgeons Scrubbing In Virtually Medtech Matters: Surgeons Scrubbing In Virtually
    FineHeart Successfully Tests Wireless TET System FineHeart Successfully Tests Wireless TET System
    Moon Surgical Expands Leadership Team Moon Surgical Expands Leadership Team
    CMS Expedites Breakthrough Device Access; Industry Applauds CMS Expedites Breakthrough Device Access; Industry Applauds
    Medtech Matters: Talking Robotic Surgery with Zimmer Biomet Medtech Matters: Talking Robotic Surgery with Zimmer Biomet
    Vonco Products Receives ISO 13485:2016 Certification Vonco Products Receives ISO 13485:2016 Certification
    BioSerenity Achieves FDA Clearance for Wearable Device System BioSerenity Achieves FDA Clearance for Wearable Device System
    Greenlight Guru and Nelson Labs Partner Greenlight Guru and Nelson Labs Partner
    Katena Products Welcomes New CEO Katena Products Welcomes New CEO
    Medtech Veteran Joins VivaLNK Board Medtech Veteran Joins VivaLNK Board
    New Company Formed to Develop Peripheral Venous Disease Treatments New Company Formed to Develop Peripheral Venous Disease Treatments
    New Global Headquarters for Freudenberg Medical New Global Headquarters for Freudenberg Medical

    Related Features

    • R&D & Design
      The Human Factors of Aesthetics

      The Human Factors of Aesthetics

      Exploring the relationship between a device’s aesthetic, human factors engineering, and purposeful design.
      Sean Hägen, Principal, Director of Research & Synthesis, BlackHägen Design 09.01.20

    • Testing
      Assessing Nanoparticles for Biocompatibility

      Assessing Nanoparticles for Biocompatibility

      It is important to have an appropriate testing protocol in place for this relatively new medical technology.
      Helin Räägel, Ph.D., Biocompatibility Expert, Nelson Laboratories 09.01.20

    • Contract Manufacturing
      Automatic Pilot: Automation Provides Solutions for Assembly Challenges

      Automatic Pilot: Automation Provides Solutions for Assembly Challenges

      Assembly and automation experts discuss the market forces and technology trends affecting the industries.
      Sam Brusco, Associate Editor 09.01.20


    • Materials
      Surface Service: Examining Coatings and Surface Treatment

      Surface Service: Examining Coatings and Surface Treatment

      Coatings and surface treatment experts can create significant value by altering the outer layer of a medical device.
      Mark Crawford, Contributing Writer 07.21.20

    • R&D & Design
      Current State of (Design) Mind

      Current State of (Design) Mind

      Medtech designers have an array of new tools to use for medical device development, enabling better solutions for healthcare.
      Mark Crawford, Contributing Writer 05.01.20

    • Contract Manufacturing
      Contract Partners: A Discussion of Full Service Outsourcing

      Contract Partners: A Discussion of Full Service Outsourcing

      Today’s outsourcing providers are more than just “hired help”; they serve as an extension of an OEM’s capabilities.
      Sean Fenske, Editor-in-Chief 05.01.20


    • R&D & Design
      Examining the Usability of Medical Software

      Examining the Usability of Medical Software

      Developers need to consider the ‘human factor’ when it comes to testing medical device software.
      Bruce Johnston, Senior Software Engineering Specialist, MedAcuity Software 04.01.20

    • R&D & Design
      Four Considerations for Developers of Next-Generation Combination Products

      Four Considerations for Developers of Next-Generation Combination Products

      Bringing together real-time monitoring, telemedicine, AI, interventions, and pharmaceuticals into a single device produces a number of potential pitfalls.
      Mark Goodman and Barry Thompson, Baker & McKenzie LLP 03.04.20

    • Testing
      Testing in Flux: Changing Protocols for a Transformative Industry

      Testing in Flux: Changing Protocols for a Transformative Industry

      As regulations and requirements around the world change, so too do the testing protocols for medical devices, sending OEMs to consult expert partners.
      Mark Crawford, Contributing Writer 03.04.20


    • Materials
      A Matter of Substance: Medical Device Materials

      A Matter of Substance: Medical Device Materials

      Medtech manufacturers are leveraging cleaner, more lightweight materials to meet increasing demand for home healthcare solutions and wearable devices.
      Michael Barbella, Managing Editor 03.04.20

    • R&D & Design
      Inventive Interaction: Medtech Research and Development in 2020

      Inventive Interaction: Medtech Research and Development in 2020

      Engaging with all stakeholders—patients, clinicians, and community members alike—is key to effective medtech R&D.
      Michael Barbella, Managing Editor 01.29.20

    • Contract Manufacturing | Materials | R&D & Design
      Delivering the Goods: The Evolving World of Combination Products

      Delivering the Goods: The Evolving World of Combination Products

      This extremely diverse market fosters relationships between medical device and pharmaceutical companies.
      Sam Brusco, Associate Editor 11.04.19


    • Materials | Molding
      Exact Science: A Micromolding Roundtable

      Exact Science: A Micromolding Roundtable

      In-vitro diagnostics and a shift toward point-of-care devices are creating a growing need for micromolded components.
      Michael Barbella, Managing Editor 10.09.19

    • Contract Manufacturing
      Assembling with Reliability and Repeatability Through Automation

      Assembling with Reliability and Repeatability Through Automation

      Progress in assembly and automation technologies enable manufacturers to leverage capabilities such as Industry 4.0 and IoT for medical device fabrication.
      Mark Crawford, Contributing Writer 09.09.19

    • Contract Manufacturing | Electronics | Neurological
      Shock to the System: An Examination of Neurostim Technologies

      Shock to the System: An Examination of Neurostim Technologies

      Targeted electrical nerve stimulation technology can aid in chronic disease management by improving on current treatment methods.
      Sam Brusco, Associate Editor 09.09.19


    Trending
    • Cytotron Gains Breakthrough Status To Treat Breast, Liver, And Pancreatic Cancers
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • An Analysis Of The Smart Inhalers Market
    • Hardy Diagnostics Releases Rapid Test For COVID-19
    Breaking News
    • Hillrom to Buy Bardy Diagnostics for $375M
    • Global Tissue and Organ Transplantation Market to Surpass $25.6 Billion by 2027
    • Owlstone Medical Introduces Breath Biopsy Panel for Respiratory Diseases
    • Cognoptix Forms a New Board of Directors
    • Occlutech's Atrial Flow Regulator Earns Breakthrough Status for HF
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Pharmaceutical Focus: A Look at Combination Products
    • The Printed World: Additive Manufacturing in Medtech
    • The Lost Year: 2020 Year in Review
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    BGG Obtains U.S. Patent on AstaZine Natural Astaxanthin for Heart Function During Exercise
    Qualitas Health/iwi Raises $10 Million in Investment Round
    Aker BioMarine Expands Krill Portfolio with Novel Protein Hydrolysate
    Coatings World

    Latest Breaking News From Coatings World

    TAUBMANS Paint by PPG Releases ‘Chromatic Joy’ Palettes
    Huntsman Finalizes Acquisition of Gabriel Performance Products
    PPG Completes COLORFUL COMMUNITIES Project at School in A. Bangsaothong Samutprakarn, Thailand
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Hillrom to Buy Bardy Diagnostics for $375M
    Global Tissue and Organ Transplantation Market to Surpass $25.6 Billion by 2027
    Owlstone Medical Introduces Breath Biopsy Panel for Respiratory Diseases
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Intravacc Completes Project for Provention Bio’s Vax Candidate
    Lonza to Exit Pharma Softgels and Liquid-Filled Hard Capsules
    Valeo Pharma Appoints President, COO
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Alastin Skincare Named as Fastest Growing Skincare Brand
    JLo Beauty Launches at Sephora & Amazon
    Unilever and Alibaba Group Join Forces
    Happi

    Latest Breaking News From Happi

    A Surge in Interest for Supplements & Vitamins
    Gattefossé Launches Inspiration Collection
    Manscaped Expands Further in Europe
    Ink World

    Latest Breaking News From Ink World

    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Techkon USA, Konica Minolta Partner
    Alon Bar-Shany Appointed Chairman of Highcon Board
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    GEW partners with RMGT
    UPM Raflatac strengthens linerless business
    Exhibitor registration opens for virtual.drupa
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Honeywell Delivered 225 Million Masks in December
    Techtextil, Texprocess Postponed to 2022
    Super Strong Inks Survive Tough Environments
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    DePuy Synthes Receives 510(k) FDA Clearance for VELYS Robotic-Assisted Solution
    OrthoPediatrics Expands Agent Network in Three European Countries
    Studies Show FlareHawk Expandable Cage Delivers Favorable Fusion, Patient Outcomes
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Graphene Flagship Launches Redesigned Website

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login